CASE STUDY - LS LAW
3-Minute Read
A healthcare compliance gap analysis and remediation roadmap
Learn how we delivered a risk-based, phased gap analysis of a specialty pharmaceutical company's healthcare compliance programme, benchmarking the current state against the desired future state, identifying and prioritising the gaps, performing root-cause analysis on the highest-risk areas, and delivering a staggered remediation roadmap with clear ownership and timelines.
Background
The client — a specialty pharmaceutical company — needed a clear, evidence-based view of where its healthcare compliance programme stood today, and a staggered, risk-based plan for getting it to where the business needed it to be. Healthcare compliance touches the activities that drive the commercial side of a pharmaceutical business: HCP interactions and engagements, transfers of value, materials review, sponsorships, grants and donations. When those activities are running across an organisation without a single line of sight on the controls, the written standards, the training and the systems behind them, gaps form quietly and surface late.
The brief was to perform a structured gap analysis — not theoretical analysis, but a practical baseline grounded in stakeholder interviews, document review, process walkthroughs and staff surveys — to identify the gaps between current state and desired future state, perform root-cause analysis on the issues that mattered, and deliver a phased remediation plan with clear ownership, timelines and a Risk-Based Prioritisation Matrix the leadership team could act on.
The LS Law Approach
Three connected workstreams: discovery, gap assessment, remediation. The engagement was structured to be collaborative, agile and risk-based: not all processes needed remediation at the same pace, so the work was sequenced so the highest-impact compliance areas were assessed and remediated first, with the lower-risk processes following on a phased timeline. Findings, recommendations and proposed scope changes were brought forward proactively at every stage rather than parked until the final report.
Discovery and stakeholder mapping. Interviews with key stakeholders to understand the business priorities, the healthcare-compliance needs, the current compliance framework and the desired future state. With support from the client, building a stakeholder map of the organisational structure and the role each individual would play in healthcare compliance — and a roadmap for embedding healthcare-compliance responsibilities across the organisation through role profiles and training.
Gap assessment and SWOT. A staggered baseline of the compliance programme: review of existing written standards and training, process walkthroughs, staff surveys on practice, knowledge and mindset, and an end-to-end resource and systems efficiency assessment. Regulatory and best-practice benchmarking against local and international requirements. A current-state-vs-future-state overview and a SWOT identifying where healthcare compliance could be embedded into the general compliance programme and where it needed to stand alone.
Root cause and remediation roadmap. Root-cause analysis with selected stakeholders on the perceived gaps, risk areas and the processes that had broken down — producing sustainable, fit-for-purpose solutions designed to prevent recurrence and strengthen risk management rather than patch the surface. A staggered remediation plan by process: written standards, systems and templates, training, accessible platforms, and an integration path for software and AI to facilitate ongoing healthcare compliance.
Methodology. Every healthcare-compliance gap analysis we run follows the same five-step structure — collaborative, transparent and adaptive — so the leadership team always knows where the engagement is, what the next milestone is, and what decisions are coming up. (1) Define the scope and objectives — agreed up-front with leadership and aligned to business priorities; discovery and information gathering through interviews, document review and system walkthroughs so the scope is set against actual practice rather than what the org chart suggests. (2) Build the stakeholder map — identify the key compliance stakeholders and how healthcare-compliance responsibilities are integrated, or need to be integrated, throughout the organisation, with a roadmap to embed them through role profiles, training and accountability. (3) Assess current vs future state (SWOT) — current-state assessment of policies, procedures and controls; regulatory and best-practice benchmarking against local and international requirements; SWOT view of strengths, weaknesses, opportunities and threats — and where healthcare compliance fits within the wider compliance programme. (4) Identify and mitigate risks — gap identification and risk prioritisation by severity, impact and urgency; root-cause analysis on the highest-impact gaps with selected stakeholders to ensure proposed solutions are sustainable, prevent recurrence and support strategic change. (5) Provide a remediation and implementation plan — staggered remediation plan by process with clear ownership and timelines; written standards, systems, templates, training, accessible platforms, and software / AI integration where it improves the operating model; phased SOP rollout aligned to compliance risk and business priorities.
Processes in scope. A staggered, risk-based approach meant assessing the more complex integrated processes (where the compliance overlay is dense and the consequences of getting it wrong are highest) at greater depth than the simpler standalone processes — and sequencing the work so the highest-priority remediation lands first. Higher-depth assessment for HCP interactions and engagements, transfers of value and materials review process — full depth: stakeholder survey, gap-analysis build, process walkthroughs, written-standards analysis, training assessment, system and resource assessment, root-cause analysis. Right-sized assessment for sponsorships, grants and donations, and commercial sponsorships — optional survey, walkthroughs, lighter-touch standards/training assessment, system review and root-cause analysis where relevant.
The Outcome
Four deliverables, designed for action. The output is a focused set of materials the leadership team and the compliance function can both read from. No theoretical analysis — the deliverables are built so the business can act on them: a Comprehensive Gap Analysis Report with identified gaps, risks and recommended actions across each process in scope, with the underlying evidence (interview findings, walkthrough notes, survey data) traceable through the report; a Risk-Based Prioritisation Matrix categorising findings high / medium / low by severity, impact and urgency so the leadership team can sequence remediation against the risks that actually move the needle; an SOP Implementation Roadmap — a staged rollout plan aligned with compliance risk and business priorities, written standards, systems, templates, training and accessible platforms phased in by impact; and an Executive Summary Presentation — a high-level findings and recommendations deck for leadership decision-making, designed to land in a Board or Exec session without further translation.
From a fragmented compliance picture to a working roadmap with clear ownership. A current-state-vs-future-state baseline of the healthcare compliance programme, a prioritised view of where the gaps and risks sit, root-causes identified rather than symptoms patched, and a phased remediation roadmap the business can run — with the option to embed software and AI tools into the operating model where they make the framework more sustainable.
Five methodology steps. Three phased delivery stages. January – March end-to-end timeline. Risk-based prioritisation throughout.
Looking for commercially-focused legal support?
Get in touch with us today to get the ball rolling.